Patrick Brannelly

Utility of the global CDR^® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium

Toji Miyagawa, Danielle Brushaber, Jeremy A. Syrjanen et al. · Alzheimer s & Dementia · 2020 · 168 citations · Full text

Medicine, Neurology, Dementia +16

Genetic screening of a large series of North American sporadic and familial frontotemporal dementia cases

Eliana Marisa Ramos, Deepika Dokuru, Victoria Van Berlo et al. · Alzheimer s & Dementia · 2020 · 79 citations · Full text

Medicine, Genetics, Neurology +13

The longitudinal evaluation of familial frontotemporal dementia subjects protocol: Framework and methodology

Bradley F. Boeve, Jessica Bove, Patrick Brannelly et al. · Alzheimer s & Dementia · 2019 · 61 citations · Full text

Medicine, Genetics, Neurology +17

Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH‐EXAMINER as a potential clinical trial endpoint

Adam M. Staffaroni, Lynn Bajorek, Kaitlin B. Casaletto et al. · Alzheimer s & Dementia · 2019 · 51 citations · Full text

Medicine, Neurology, Neuroscience +17

Clinical and volumetric changes with increasing functional impairment in familial frontotemporal lobar degeneration

Nicholas Olney, Elise Ong, Sheng‐Yang M. Goh et al. · Alzheimer s & Dementia · 2019 · 45 citations · Full text

Medicine, Genetics, Neurology +17